Akcea Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 294
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Akcea Therapeutics General Information

Description

Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 22 Boston Wharf Road
  • 9th Floor
  • Boston, MA 02210
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akcea Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial

Akcea Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs t
Biotechnology
Boston, MA
294 As of 2019
00000
0.000 0000-00-00
000000&0 00000

000 0000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000000 00000

000000 0

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000000000
Foster City, CA
00000 As of 0000
00.000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akcea Therapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
000000 000000 Formerly VC-backed Marseille, France 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Newark, CA 00 00000 00000000 00000
00000000 000000000 Venture Capital-Backed Newton, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

Akcea Therapeutics Executive Team (17)

Name Title Board Seat Contact Info
Michael Price Executive Vice President & Chief Financial Officer
Tracy Berns Chief Compliance Officer
Carla Poulson Chief Human Resources Officer & Senior Vice President
Kyle Jenne Chief Commercial Officer
Christophe Hotermans MD Senior Vice President, Global Medical Affairs
You’re viewing 5 of 17 executive team members. Get the full list »

Akcea Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akcea Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial